Law360, New York (October 12, 2007) -- Toyko-based drug company Eisai Co. Ltd. has reached a sort of detente with generic drugmakers Mutual Pharmaceuticals Company, Inc. and United Research Laboratories Inc. in a patent dispute over the billion-dollar Alzheimer's treatment Aricept.
Judge Esther Salas signed off on the stipulation and order Wednesday, approving an agreement which says that URL/Mutual will not sell a generic product containing the active ingredient of Aricept,...
